| 摘要 |
<p>ABSTRACT - 599513 The disclosure relates to compounds of the general formula (I), e.g. N-(benzyloxy)-2-methyl-5-((5-methyl-2-phenyloxazol-4-yl)methyl)-1,3-dioxane-2-carboxamide their tautomeric forms, their stereoisomers, regioisomers and their pharmaceutically acceptable salts, wherein the variables are as defined in the specification. These compounds are suitable for the treatment of dyslipidemia and related diseases.</p> |
